These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28027672)
1. Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta. Büke B; Akkaya H; Demir S; Sağol S; Şimşek D; Başol G; Barutçuoğlu B J Matern Fetal Neonatal Med; 2018 Jan; 31(1):59-62. PubMed ID: 28027672 [TBL] [Abstract][Full Text] [Related]
2. First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation. Thompson O; Otigbah C; Nnochiri A; Sumithran E; Spencer K BJOG; 2015 Sep; 122(10):1370-6. PubMed ID: 25639820 [TBL] [Abstract][Full Text] [Related]
3. Elevated first trimester PAPP--a is associated with increased risk of placenta accreta. Desai N; Krantz D; Roman A; Fleischer A; Boulis S; Rochelson B Prenat Diagn; 2014 Feb; 34(2):159-62. PubMed ID: 24226752 [TBL] [Abstract][Full Text] [Related]
4. First trimester serum PAPP-A is associated with placenta accreta: a retrospective study. Wang F; Chen S; Wang J; Wang Y; Ruan F; Shu H; Zhu L; Man D Arch Gynecol Obstet; 2021 Mar; 303(3):645-652. PubMed ID: 33515274 [TBL] [Abstract][Full Text] [Related]
5. Significance of the routine first-trimester antenatal screening program for aneuploidy in the assessment of the risk of placenta accreta spectrum disorders. Penzhoyan GA; Makukhina TB J Perinat Med; 2019 Dec; 48(1):21-26. PubMed ID: 31730533 [TBL] [Abstract][Full Text] [Related]
6. Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete. Zhou J; Li J; Yan P; Ye YH; Peng W; Wang S; Wang XT Placenta; 2014 Sep; 35(9):691-5. PubMed ID: 25063251 [TBL] [Abstract][Full Text] [Related]
7. Elevated first-trimester PAPP-A is a marker in high-risk pregnancies with an increased risk of placenta accreta in predicting adverse outcomes. Balkaş G; Çaglar T Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9955-9961. PubMed ID: 37916365 [TBL] [Abstract][Full Text] [Related]
8. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study. Berezowsky A; Pardo J; Ben-Zion M; Wiznitzer A; Aviram A Fetal Diagn Ther; 2019; 46(3):187-192. PubMed ID: 30726846 [TBL] [Abstract][Full Text] [Related]
10. Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A. Tul N; Pusenjak S; Osredkar J; Spencer K; Novak-Antolic Z Prenat Diagn; 2003 Dec; 23(12):990-6. PubMed ID: 14663836 [TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies. Giorgetti C; Vanden Meerschaut F; De Roo C; Saunier O; Quarello E; Hairion D; Penaranda G; Chabert-Orsini V; De Sutter P Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070 [TBL] [Abstract][Full Text] [Related]
12. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus. Savvidou MD; Syngelaki A; Muhaisen M; Emelyanenko E; Nicolaides KH BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916 [TBL] [Abstract][Full Text] [Related]
13. Does diurnal variation affect the first trimester fetal aneuploidy screening test biochemical parameters of fetuses with normal nuchal translucency? Karsli MF; Cakmak B; Seckin KD; Akkas Yilmaz E; Akgul G; Togrul C; Kucukozkan T J Matern Fetal Neonatal Med; 2016; 29(11):1808-11. PubMed ID: 26135776 [TBL] [Abstract][Full Text] [Related]
14. A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers. Sweeting AN; Wong J; Appelblom H; Ross GP; Kouru H; Williams PF; Sairanen M; Hyett JA J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2122-2130. PubMed ID: 28562122 [TBL] [Abstract][Full Text] [Related]
15. First trimester screening for other trisomies than trisomy 21, 18, and 13. Tørring N; Petersen OB; Becher N; Vogel I; Uldbjerg N; ; Prenat Diagn; 2015 Jun; 35(6):612-9. PubMed ID: 25708180 [TBL] [Abstract][Full Text] [Related]
16. The impact of inherited thrombophilia on first trimester combined aneuploidy screening test parameters. Karsli MF; Baser E; Seckin KD; Yeral Mİ; Togrul C; Ugur M J Matern Fetal Neonatal Med; 2014 Mar; 27(4):346-9. PubMed ID: 23795618 [TBL] [Abstract][Full Text] [Related]
17. First trimester serum PIGF is associated with placenta accreta. Wang F; Zhang L; Zhang F; Wang J; Wang Y; Man D Placenta; 2020 Nov; 101():39-44. PubMed ID: 32916477 [TBL] [Abstract][Full Text] [Related]
18. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705 [TBL] [Abstract][Full Text] [Related]
19. First-trimester markers of aneuploidy in women positive for HIV. Savvidou MD; Samuel I; Syngelaki A; Poulton M; Nicolaides KH BJOG; 2011 Jun; 118(7):844-8. PubMed ID: 21062401 [TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of specific proteins of pregnancy in women with a uterine scar and placenta accreta.]. Borovkov VA; Igitova MB; Korenovskiy YV; Dudareva YA Klin Lab Diagn; 2020; 65(6):353-357. PubMed ID: 32459893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]